upstreambio.com (UPB) - Yakuniy foyda

UPB (Upstream Bio, Inc.) - kompaniyaning tovar belgisi

Ushbu grafik Upstream Bio Inc (UPB) kompaniyasining foyda dinamikasini aks ettiruvchi narxlar tendentsiyasini ko'rsatadi, u -0.16 darajasida turibdi. Upstream Bio Inc (UPB) og'ir astma holatlarida yallig'lanish jarayonlarini samarali bostiruvchi verekitumab orqali narxlarni belgilash imkoniyati uchun asos yaratmoqda. Biznes modeli ishlab chiqarish va sinovlarni autsorsing qilishga tayanadi, inqirozga chidamlilik esa avtonom innovatsion rivojlanish sikli orqali ta'minlanadi.

UPB Upstream Bio Inc Kompaniyaning sof foydasi (12.10.2024 - 29.10.2026)

Upstream Bio (UPB) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Aksiya narxi Upstream Pharma|UPB - Konsensus maqsadli narx
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Upstream Pharma|UPB - Korxona qiymati
- biznesning balans baholash tafsilotlari:
Aksiya hisobiga sof aktivlar Upstream Bio|UPB - Kompaniyaning balans qiymati|Kapitallashuvning sof aktivlarga nisbati upstreambio.com|UPB - Kompaniyaning jami aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning xususiy kapitalga nisbati Upstream Bio Inc|UPB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Upstream Bio, Inc.|UPB - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Upstream Pharma|UPB - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Upstream Bio|Tezkor likvidlik koeffitsiyenti upstreambio.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
UPB - Kompaniyaning sof foydasi
Kompaniyaning asosiy tahlili:Upstream Pharma
Upstream Bio asosiy tovari

Upstream Bio Inc (UPB) yallig'lanishga qarshi dori vositalarini ishlab chiqishni yuqori texnologiyali sovuq zanjir logistikasi bilan birlashtiradi. Sof foyda barcha operatsion xarajatlar va soliqlarni chegirib tashlagandan keyingi yakuniy moliyaviy natijani o'lchaydi. Tashkilotning sof foydasidagi tendentsiya qarz boshqaruvining samaradorligini va makroshoklarga chidamliligini aks ettiradi. Barqaror o'sish diversifikatsiyalashgan laboratoriyalarning daromadli ekanligini va ta'minot zanjirlarining ishonchliligini tasdiqlaydi. Ushbu aktiv yuqori xavfli biotexnologik investitsiyalar toifasiga kiradi.

Toʻgʻridan-toʻgʻri raqobatchilar

argenx BVBA (ARGX) - Sof foyda|Sof daromad BNTX|ABVX: Yakuniy foyda|Sof foyda ADMA|Sof moliyaviy natija Protagonist Therapeutics, Inc.|Kompaniyaning sof foydasi Immunovant Corp IMVT|KNSA - Sof daromad|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|CLDX (Celldex Therapeutics, Inc.) - Sof daromad|Aurinia Pharmaceuticals Inc (AUPH) - Sof foyda|Kompaniyaning sof foydasi BioCryst Pharmaceuticals Inc|Kompaniya foydasi VERA (Vera Corp)|Sof foyda DNTH|PHVS - Kompaniyaning sof daromadi|AbCellera Biologics Inc - Sof daromad|Sof foyda Tourmaline Bio Inc TRML|PGEN - Kompaniyaning sof foydasi|Soliqdan keyingi foyda PHAR|Nektar Therapeutics (NKTR) - Kompaniyaning sof foydasi|ZBIO - Sof moliyaviy natija|Sof daromad IMNM|GOSS (Gossamer Bio Inc) - Soliqlar to‘langandan keyingi foyda|Kompaniyaning sof foydasi KalVista Pharmaceuticals Inc (KALV)|SEPN (Septerna Pharma) - Yakuniy foyda|Sof foyda PVLA (Pieris Pharmaceuticals)|savarapharma.com (SVRA) - Kompaniyaning sof daromadi|Rigel Pharmaceuticals, Inc. - Sof foyda|ANAB - Sof foyda|Astria Pharma (ATXS) - Kompaniyaning sof foydasi|Sof daromad enGene Corp|Sof daromad RAPT|JBIO: Yakuniy foyda|Sof foyda ACRS|Kompaniyaning sof foydasi KYTX (Kyverna Therapeutics Inc.)|Sof foyda TLSA (Tiziana Life Sciences PLC)|Sof moliyaviy natija Cabaletta Bio Inc (CABA)|VTYX - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi theratech.com|AVTX (Avalo Therapeutics) - Sof daromad|Eledon Pharmaceuticals Inc. - Yakuniy foyda|AGEN (Agenus Inc) - Sof foyda|Climb Bio, Inc (CLYM) - Sof moliyaviy natija|Kompaniyaning sof foydasi Zura Bio Limited (ZURA)|atyrpharma.com - Kompaniya foydasi|Sof foyda ADAG (Adagene Inc.)|IMA - Sof daromad|STTK: Sof daromad|EQ - Sof foyda|connectbiopharm.com (CNTB) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda IMUX (Immunic)|ATRA (Atara Biotherapeutics, Inc.) - Sof foyda|Kompaniyaning sof foydasi IFRX|Kompaniyaning sof foydasi X4 Pharma (XFOR)|ACET: Soliqdan keyingi foyda|Sof foyda CELU (Celularity)|Yakuniy foyda INMB|Barinthus Biotherapeutics plc - Sof foyda|KZR - Sof foyda|SAB Biotherapeutics, Inc (SABS) - Kompaniyaning sof foydasi|Akari Therapeutics, Plc - Yakuniy foyda|Kompaniyaning sof foydasi Enlivex Therapeutics Ltd|Sof daromad Q32 Bio Corp (QTTB)|Sof foyda GOVX|Sof foyda Edesa Biotech Inc (EDSA)|iBio Corp - Sof daromad|Yakuniy foyda CARM|XTL Biopharmaceuticals - Sof foyda|Sof moliyaviy natija Bolt Biotherapeutics BOLT|hcwbiologics.com (HCWB) - Kompaniyaning sof foydasi|Sof daromad Aptevo Therapeutics Inc.|Kompaniyaning sof foydasi AIM ImmunoTech|Sof daromad Aditxt Corp (ADTX)|Sof daromad GRI (GRI Bio, Inc.)|Sof foyda xortx.com (XRTX)|Kompaniyaning sof foydasi Vyome Holdings HIND|REVB: Kompaniya foydasi|Indaptus - Sof foyda|Kompaniyaning sof daromadi BiondVax Pharmaceuticals|CALI (calcimedica.com) - Sof daromad|Affimed N.V. (AFMD) - Sof foyda|Kompaniyaning sof foydasi Allakos Inc|HOOKIPA - Soliqdan keyingi foyda|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|Sof moliyaviy natija iTeos Pharma|Ocean Biomedical, Inc. - Sof daromad|Soliqlar to‘langandan keyingi foyda TCBP (tcbiopharm.com)|THRD - Kompaniyaning sof foydasi